While up to 70% of people with epilepsy are able to control their seizures with antiepileptic drugs, about 30% continue to experience seizures despite the availability of many such medications. Some individuals experience very few epileptic seizures, while others suffer from numerous severe and damaging seizures on a daily basis. Regardless of the frequency of these events, epilepsy can significantly impact one’s quality of life. Consequently, this gap in treatment has led some people to seek alternatives, including CBD.
Epilepsy and CBD: Research suggests that compounds derived from the cannabis plant may reduce the severity and frequency of seizures in some individuals—particularly in children with catastrophic epileptic disorders. There is evidence that using CBD in combination with other treatments can be beneficial for certain patients with specific conditions.
Evidence
The evidence supporting the use of CBD is strongest regarding the treatment of certain types of epileptic seizures in children. When antiepileptic drugs fail to fully control the condition, CBD-based products—used as an adjunctive (supplementary) treatment—may improve the quality of life for children and young adults under the age of 25.
What is epilepsy?
Epilepsy is a tendency to experience recurrent seizures. While there are many different types of seizures, they all result from abnormal electrical activity in some part of the brain. A seizure occurs when nerve cells in the brain malfunction, triggering a sudden, uncontrolled burst of electrical activity.
This disrupts the orderly communication between nerve cells, causing thoughts, feelings, or movements to become temporarily confused or uncontrolled. Many people experience a seizure at some point in their lives, but this does not necessarily mean they have epilepsy, as the risk of recurrence is low. For many children with epilepsy, the condition resolves by the time they reach adulthood. For others, the tendency toward recurrent seizures may be a lifelong predisposition.
What is CBD?
Cannabidiol, or CBD, is found in the stems and flowers of the cannabis plant and does not possess mind-altering properties. It has shown positive effects on certain bodily systems and may help manage epileptic seizures. Unlike recreational cannabis, CBD does not contain the properties that produce a "high." It is a completely legal product in the Netherlands because it contains only very low levels of THC. However, cannabidiol containing higher levels of THC (above 0.3%) is illegal.
The term "cannabidiol" is also used in reference to cannabinoids—chemical substances found within the plant that interact with cells (receptors) in the body. There are over 100 cannabinoids in the cannabis plant. Two primary components currently under research are tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is the main psychoactive component of cannabis. Regarding the effect of CBD on epilepsy, it has been demonstrated that CBD—one of the primary cannabinoid components of cannabis—possesses antiepileptic, anxiolytic (anti-anxiety), and antipsychotic properties.
CBD interacts—either directly or indirectly—with many different receptors in the brain. It indirectly affects the brain's primary cannabinoid receptor by reducing its stimulation. It also interacts with a variety of other receptors.

